A vaccine against coronavirus infection COVID-19, that is developed by scientists at Oxford University, will be tested on humans since April 23. On the 21st of April, said the Minister of health of great Britain Matt Hancock at a briefing broadcast which led the Guardian News.
“The Ministry of health is providing £20 million Oxford experts on the funding of clinical trials. Vaccines will be tested on humans starting this Thursday,” said Hancock.
According to him, another £22.5 million will go to vaccine trials at Imperial College London.
“We start to apply the vaccine as soon as possible,” he said.
Hancock noted that “two of the world’s leading development of vaccines are at Oxford and Imperial”.
In the UK the number of infected persons was 125 856, died 16 550, 603 I recovered.
Flash coronavirus infection COVID-19 began in December 2019 in the Chinese city of Wuhan. March 11, the world health organization declared the spread of the coronavirus pandemic. According to data from the American Johns Hopkins University on April 21, the total number of infected people in the world exceeded 2.5 million, of which 171,8 thousand died, more 659,7 thousand recovered.
Special medications from coronavirus infection COVID-19 does not exist now in this disease is only symptomatic treatment. The world health organization notedthat a number of medicines can contribute to improved well-being and relief of symptoms COVID-19, but there is no evidence that any drug to prevent or treat the disease.
According to the world health organization in the world is developed not less than 70 vaccines against coronavirus. Human trials have also started companies in China and the United States.